Eli Lilly Expands Oncology Ambitions with Up to $2.3 Billion Ajax Therapeutics Acquisition
Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...
India–New Zealand FTA Opens Zero-Duty Pharma Gateway, Boosting ‘Made in India’ Healthcare Exports
In a significant boost for India’s healthcare and pharmaceutical ecosystem, the newly signed India–New Zealand Free Trade Agreement (FTA) is set to create powerful...
Sun Pharma to Acquire Organon in Transformative $11.75 Billion Deal Focused on Women’s Health
Sun Pharma has announced a landmark definitive agreement to acquire Organon in an all-cash transaction valued at approximately $11.75 billion, marking one of the...
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...
Cipla Secures U.S. FDA Approval for First AB-Rated Generic Therapeutic Equivalent to Ventolin® HFA
The United States Food and Drug Administration (USFDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol,...
IPC Forges Strategic Alliances with PMBI and NIPER Hajipur to Redefine India’s Drug Safety and Pharma Research Landscape
Under the visionary leadership of Hon’ble Prime Minister Shri Narendra Modi, India continues to fortify its commitment to accessible, high-quality healthcare. In a landmark...